BARD1 Life Sciences Ltd. said nonexecutive director Geoffrey Laurent died Aug. 12.
Laurent joined the Australian cancer drug developer's board in 2016.
Discover more about S&P Global’s offerings
BARD1 Life Sciences director dies
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
BARD1 Life Sciences Ltd. said nonexecutive director Geoffrey Laurent died Aug. 12.
Laurent joined the Australian cancer drug developer's board in 2016.